Global lab automation market is projected to register a substantial CAGR of 6.6%% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029.
Market Segmentation:
Global Lab Automation Market, By Product Type (Equipment, Software & Informatics, Analyzer), Automation Type (Modular Automation, Total Lab Automation), Application (Drug Discovery, Clinical Diagnostics, Genomics Solutions, Proteomics Solutions, Bio Analysis, Protein Engineering, Lyophilization, System Biology, Analytical Chemistry), End Users (Biotechnology & Pharmaceuticals, Hospitals & Laboratories, Research and Academic Institutions, and Others), Countries (U.S., Canada, Mexico, Germany, France, U.K, Italy, Spain, Netherlands, Russia, Denmark, Switzerland, Turkey, Sweden, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, New Zealand, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Ethiopia, UAE, and Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
Some of the major factors contributing to the growth of the market are:
Growing expenditure on lab automation tools and equipment
Rising healthcare expenditure
Market Players:
Some of the key market players in global lab automation market are listed below:
Danaher
PerkinElmer Inc.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
QIAGEN
F. Hoffman-La Roche Ltd
Siemens Healthcare GmbH
Abbott
Aurora Biomed Inc.
BD
BIOMERIEUX
Eppendorf SE
LabVantage Solutions Inc.
LabWare
LabLynx LIMS
TABLE OF CONTENTS
1 INTRODUCTION 30
- 1.1 OBJECTIVES OF THE STUDY 30
- 1.2 MARKET DEFINITION 30
- 1.3 OVERVIEW OF THE GLOBAL LAB AUTOMATION MARKET 30
- 1.4 LIMITATIONS 32
- 1.5 MARKETS COVERED 32
2 MARKET SEGMENTATION 34
- 2.1 MARKETS COVERED 34
- 2.2 GEOGRAPHICAL SCOPE 35
- 2.3 YEARS CONSIDERED FOR THE STUDY 36
- 2.4 CURRENCY AND PRICING 36
- 2.5 DBMR TRIPOD DATA VALIDATION MODEL 37
- 2.6 MULTIVARIATE MODELLING 40
- 2.7 PRODUCT TYPE LIFELINE CURVE 40
- 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 41
- 2.9 DBMR MARKET POSITION GRID 42
- 2.10 MARKET END USER COVERAGE GRID 43
- 2.11 VENDOR SHARE ANALYSIS 44
- 2.12 SECONDARY SOURCES 45
- 2.13 ASSUMPTIONS 45
3 EXECUTIVE SUMMARY 46
4 PREMIUM INSIGHTS 48
- 4.1 PESTEL ANALYSIS 51
- 4.2 PORTER'S FIVE FORCES 52
5 REGULATION 53
6 MARKET OVERVIEW 55
- 6.1 DRIVERS 57
- 6.1.1 INCREASING INVESTMENT & STRATEGIC INITIATIVES BY MARKET PLAYERS 57
- 6.1.2 GOVERNMENT INITIATIVES TO STRENGTHEN LABORATORY INFRASTRUCTURES 57
- 6.1.3 GROWING EXPENDITURE ON LAB AUTOMATION TOOLS AND EQUIPMENT 57
- 6.1.4 REDUCING HUMAN EFFORTS AND ELIMINATING HUMAN ERROR 58
- 6.2 RESTRAINTS 58
- 6.2.1 LIMITATION ANALYZING NOVEL COMPLEX PRODUCT 58
- 6.2.2 HIGH COST FOR INSTALLATION AND SETUP 58
- 6.2.3 UPGRADATION, MAINTENANCE, AND PERIODICAL CHECKUPS 59
- 6.3 OPPORTUNITIES 59
- 6.3.1 RISING HEALTHCARE EXPENDITURE 59
- 6.3.2 STRATEGIC INITIATIVES BY KEY PLAYERS 60
- 6.3.3 RISE IN THE NUMBER OF PHARMA COMPANIES 60
- 6.4 CHALLENGES 61
- 6.4.1 SLOW ADOPTION OF AUTOMATION AMONG SMALL AND MEDIUM SIZED LABORATORIES 61
- 6.4.2 LIMITED FEASIBILITY WITH TECHNOLOGY INTEGRATION IN ANALYTICAL LABS 61
7 GLOBAL LAB AUTOMATION MARKET, BY PRODUCT TYPE 62
- 7.1 OVERVIEW 63
- 7.2 EQUIPMENT 66
- 7.2.1 AUTOMATED WORKSTATIONS 66
- 7.2.1.1 AUTOMATED LIQUID HANDLING SYSTEMS 66
- 7.2.1.2 AUTOMATED INTEGRATED WORKSTATIONS 66
- 7.2.1.3 PIPETTING SYSTEMS 67
- 7.2.1.4 MICROPLATE WASHERS 67
- 7.2.1.5 REAGENT DISPENSERS 67
- 7.2.2 MICROPLATE READERS 67
- 7.2.2.1 MULTI-MODE MICROPLATE READERS 67
- 7.2.2.2 SINGLE-MODE MICROPLATE READERS 67
- 7.2.2.3 AUTOMATED NUCLEIC ACID PURIFICATION SYSTEMS 67
- 7.2.2.4 AUTOMATED ELISA SYSTEMS 68
- 7.2.3 OFF-THE-SHELF AUTOMATED WORKCELLS 68
- 7.2.4 ROBOTIC SYSTEMS 68
- 7.2.4.1 ROBOTIC ARMS 68
- 7.2.4.2 TRACK ROBOTS 68
- 7.2.5 AUTOMATE STORAGE & RETRIEVALS (ASRS) 68
- 7.2.6 OTHERS 68
- 7.3 ANALYZER 68
- 7.3.1 BIO CHEMISTRY ANALYZERS 69
- 7.3.2 HAEMATOLOGY ANALYZERS 69
- 7.3.3 IMMUNO-BASED ANALYZERS 69
- 7.4 SOFTWARE & INFORMATICS 69
- 7.4.1 LABORATORY INFORMATION MANAGEMENT SYSTEM (LIMS) 70
- 7.4.2 ELECTRONIC LABORATORY NOTEBOOK (ELN) 70
- 7.4.3 LABORATORY EXECUTION SYSTEMS (LES) 70
- 7.4.4 SCIENTIFIC DATA MANAGEMENT SYSTEMS (SDMS) 71
8 GLOBAL LAB AUTOMATION MARKET, BY AUTOMATION TYPE 72
- 8.1 OVERVIEW 73
- 8.2 TOTAL LAB AUTOMATION 76
- 8.3 MODULAR AUTOMATION 76
9 GLOBAL LAB AUTOMATION MARKET, BY APPLICATION 77
- 9.1 OVERVIEW 78
- 9.2 CLINICAL DIAGNOSTICS 81
- 9.3 DRUG DISCOVERY 81
- 9.4 GENOMICS SOLUTIONS 81
- 9.5 PROTEOMIC SOLUTIONS 82
- 9.6 ANALYTICAL CHEMISTRY 82
- 9.7 PROTEIN ENGINEERING 83
- 9.8 BIO ANALYSIS 83
- 9.9 SYSTEM BIOLOGY 84
- 9.10 OTHERS 84
10 GLOBAL LAB AUTOMATION MARKET, BY END USER 86
- 10.1 OVERVIEW 87
- 10.2 BIOTECHNOLOGY & PHARMACEUTICALS 90
- 10.3 HOSPITALS & LABORATORIES 90
- 10.4 RESEARCH & ACADEMIC INSTITUTES 90
- 10.5 OTHERS 91
11 GLOBAL LAB AUTOMATION MARKET, BY REGION 92
- 11.1 OVERVIEW 93
- 11.2 NORTH AMERICA 98
- 11.2.1 U.S. 106
- 11.2.2 CANADA 109
- 11.2.3 MEXICO 113
- 11.3 EUROPE 117
- 11.3.1 GERMANY 125
- 11.3.2 FRANCE 128
- 11.3.3 U.K. 132
- 11.3.4 ITALY 136
- 11.3.5 RUSSIA 140
- 11.3.6 SPAIN 144
- 11.3.7 NETHERLANDS 147
- 11.3.8 SWITZERLAND 151
- 11.3.9 TURKEY 155
- 11.3.10 BELGIUM 159
- 11.3.11 REST OF EUROPE 163
- 11.4 ASIA-PACIFIC 164
- 11.4.1 CHINA 172
- 11.4.2 JAPAN 176
- 11.4.3 SOUTH KOREA 180
- 11.4.4 INDIA 184
- 11.4.5 AUSTRALIA 188
- 11.4.6 SINGAPORE 192
- 11.4.7 THAILAND 196
- 11.4.8 MALAYSIA 200
- 11.4.9 INDONESIA 204
- 11.4.10 PHILIPPINES 208
- 11.4.11 REST OF ASIA-PACIFIC 212
- 11.5 SOUTH AMERICA 213
- 11.5.1 BRAZIL 221
- 11.5.2 ARGENTINA 225
- 11.5.3 REST OF SOUTH AMERICA 229
- 11.6 MIDDLE EAST AND AFRICA 230
- 11.6.1 SOUTH AFRICA 238
- 11.6.2 SAUDI ARABIA 242
- 11.6.3 U.A.E. 246
- 11.6.4 REST OF MIDDLE EAST AND AFRICA 250
12 GLOBAL LAB AUTOMATION MARKET: COMPANY LANDSCAPE 251
- 12.1 COMPANY SHARE ANALYSIS: GLOBAL 251
- 12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 252
- 12.3 COMPANY SHARE ANALYSIS: EUROPE 253
- 12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 254
13 SWOT ANALYSIS 255
14 COMPANY PROFILE 256
- 14.1 THERMO FISHER SCIENTIFIC INC. 256
- 14.1.1 COMPANY SNAPSHOT 256
- 14.1.2 REVENUE ANALYSIS 257
- 14.1.3 COMPANY SHARE ANALYSIS 257
- 14.1.4 PRODUCT PORTFOLIO 257
- 14.1.5 RECENT DEVELOPMENTS 258
- 14.2 DANAHER 259
- 14.2.1 COMPANY SNAPSHOT 259
- 14.2.2 REVENUE ANALYSIS 259
- 14.2.3 COMPANY SHARE ANALYSIS 260
- 14.2.4 PRODUCT PORTFOLIO 260
- 14.2.5 RECENT DEVELOPMENTS 260
- 14.3 F. HOFFMANN- LA ROCHE LTD 261
- 14.3.1 COMPANY SNAPSHOT 261
- 14.3.2 REVENUE ANALYSIS 261
- 14.3.3 COMPANY SHARE ANALYSIS 262
- 14.3.4 PRODUCT PORTFOLIO 262
- 14.3.5 RECENT DEVELOPMENTS 262
- 14.4 PERKINELMER INC 264
- 14.4.1 COMPANY SNAPSHOT 264
- 14.4.2 REVENUE ANALYSIS 265
- 14.4.3 COMPANY SHARE ANALYSIS 265
- 14.4.4 PRODUCT PORTFOLIO 266
- 14.4.5 RECENT DEVELOPMENTS 266
- 14.5 BD 267
- 14.5.1 COMPANY SNAPSHOT 267
- 14.5.2 REVENUE ANALYSIS 267
- 14.5.3 COMPANY SHARE ANALYSIS 268
- 14.5.4 PRODUCT PORTFOLIO 268
- 14.5.5 RECENT DEVELOPMENTS 268
- 14.6 ABBOTT 269
- 14.6.1 COMPANY SNAPSHOT 269
- 14.6.2 REVENUE ANALYSIS 269
- 14.6.3 PRODUCT PORTFOLIO 270
- 14.6.3 RECENT DEVELOPMENTS 270
- 14.7 AGILENT TECHNOLOGIES 271
- 14.7.1 COMPANY SNAPSHOT 271
- 14.7.2 REVENUE ANALYSIS 271
- 14.7.3 PRODUCT PORTFOLIO 272
- 14.7.4 RECENT DEVELOPMENTS 272
- 14.8 AURORA BIOMED INC. 273
- 14.8.1 COMPANY SNAPSHOT 273
- 14.8.2 PRODUCT PORTFOLIO 273
- 14.8.3 RECENT DEVELOPMENTS 273
- 14.9 AZENTA US INC 274
- 14.9.1 COMPANY SNAPSHOT 274
- 14.9.2 REVENUE ANALYSIS 274
- 14.9.3 PRODUCT PORTFOLIO 275
- 14.9.4 RECENT DEVELOPMENTS 275
- 14.10 BIOMERIEUX 276
- 14.10.1 COMPANY SNAPSHOT 276
- 14.10.2 REVENUE ANALYSIS 276
- 14.10.3 PRODUCT PORTFOLIO 277
- 14.10.4 RECENT DEVELOPMENTS 277
- 14.11 EPPENDORF SE 278
- 14.11.1 COMPANY SNAPSHOT 278
- 14.11.2 PRODUCT PORTFOLIO 278
- 14.11.3 RECENT DEVELOPMENTS 278
- 14.12 HAMILTON COMPANY 279
- 14.12.1 COMPANY SNAPSHOT 279
- 14.12.2 PRODUCT PORTFOLIO 279
- 14.12.3 RECENT DEVELOPMENTS 279
- 14.13 HUDSON ROBOTICS 280
- 14.13.1 COMPANY SNAPSHOT 280
- 14.13.2 PRODUCT PORTFOLIO 280
- 14.13.3 RECENT DEVELOPMENTS 280
- 14.14 LABLYNX LIMS 281
- 14.14.1 COMPANY SNAPSHOT 281
- 14.14.2 PRODUCT PORTFOLIO 281
- 14.14.3 RECENT DEVELOPMENTS 281
- 14.15 LABVANTAGE SOLUTIONS INC. 282
- 14.15.1 COMPANY SNAPSHOT 282
- 14.15.2 PRODUCT PORTFOLIO 282
- 14.15.3 RECENT DEVELOPMENTS 282
- 14.16 LABWARE 283
- 14.16.1 COMPANY SNAPSHOT 283
- 14.16.2 PRODUCT PORTFOLIO 283
- 14.16.3 RECENT DEVELOPMENTS 283
- 14.17 QIAGEN 284
- 14.17.1 COMPANY SNAPSHOT 284
- 14.17.2 REVENUE ANALYSIS 284
- 14.17.3 PRODUCT PORTFOLIO 285
- 14.17.4 RECENT DEVELOPMENTS 285
- 14.18 SIEMENS HEALTHCARE GMBH 287
- 14.18.1 COMPANY SNAPSHOT 287
- 14.18.2 REVENUE ANALYSIS 287
- 14.18.3 PRODUCT PORTFOLIO 288
- 14.18.4 RECENT DEVELOPMENTS 288
- 14.19 TECAN TRADING AG 289
- 14.19.1 COMPANY SNAPSHOT 289
- 14.19.2 REVENUE ANALYSIS 289
- 14.19.3 PRODUCT PORTFOLIO 290
- 14.19.4 RECENT DEVELOPMENTS 290
15 QUESTIONNAIRE 291
16 RELATED REPORTS 294